Clinical Trials Logo

Clinical Trial Summary

The purpose of study is to provide an objective data for evaluating the efficacy and safety of Chinese medicine (CM) formula combined with inhaled corticosteroid in the treatment of asthmatic children. Investigators will recruit eighty-six mild to moderate asthmatic children aged 4-11 years old with regular ICS usage and they will be randomized into two groups in this double-blind trial. Forty-three subjects will receive CM (CM group; Ma-Hsing-Kan-Shih-Tang in combination with Liu-Jun-Zi-Tang) and the other forty-three subjects will receive placebo (placebo group; 10% CM) for 12 weeks. Investigators will compare these two groups by questionnaires of Childhood Asthma Control Test (cACT), the Integrated Therapeutics Group Child Asthma Short Form (ITG-CASF), Pediatric Asthma Caregiver's Quality of Life Questionnaire (PACQLQ), the pulmonary function test and blood test including Complete Blood Count with Differential Count (CBC/DC), total IgE, Eosinophil Cationic Protein (ECP) and IL-4/IL-5/IL-13. Adverse events, renal and liver function test will be evaluated to investigate the safety of CM formula as well.


Clinical Trial Description

Treating pediatric asthma has been in accordance with GINA guidelines by stepwise approach to adjust treatment for individual patient needs. However, most of the asthma controller medication nowadays is inhaled corticosteroids (ICS). Parents with steroid phobia may raise concern and fears about the potential systemic effects, leading to poor adherence to medication and worse control. This study aims to evaluate the efficacy and safety of Chinese medicine (CM) formula combined with inhaled corticosteroid for the treatment of mild to moderate persistent asthma in children. Investigators focus on the following specific aims: Aim 1. To determine the efficacy of the CM formula (Ma-Hsing-Kan-Shih-Tang in combination with Liu-Jun-Zi-Tang) compared with placebo; Aim 2. To evaluate the effects of CM formula on quality of life in these patients with pediatric asthma; Aim 3. To investigate the safety of CM formula in these patients with pediatric asthma. Eighty-six mild to moderate asthmatic children aged 4-11 years old with regular ICS usage will be randomized into two groups in this double-blind trial. Forty-three subjects will receive CM (CM group; Ma-Hsing-Kan-Shih-Tang in combination with Liu-Jun-Zi-Tang) and the other forty-three subjects will receive placebo (placebo group; 10% CM) for 12 weeks. The evaluation including pulmonary function test, IOS, FeNO, blood test, questionnaire and asthma diary card of both two groups will be conducted during the study period. The safety of CM formula use will be investigated by recording the adverse events and renal and liver function test as well. This study will provide an objective data for evaluating the efficacy and safety o of Chinese medicine (CM) formula combined with inhaled corticosteroid in the treatment of asthmatic children. Through the combination of Chinese and western medicine, we expect to enhance the efficacy of asthma treatment, reduce acute exacerbation and tapper the dose of inhaled corticosteroids, leading to better quality of life. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05066841
Study type Interventional
Source China Medical University Hospital
Contact Chieh Wang
Phone +886963619537
Email [email protected]
Status Recruiting
Phase N/A
Start date September 25, 2021
Completion date September 30, 2023

See also
  Status Clinical Trial Phase
Completed NCT04617015 - Defining and Treating Depression-related Asthma Early Phase 1
Not yet recruiting NCT05064579 - Towards an Algorithmic Approach to Asthma Management: Collaborative Definition of Algorithm Objectives With Families
Completed NCT01450774 - Comparison of Combination of Beclomethasone Dipropionate and Formoterol Fumarate Versus Single Components Assessed by Knemometry and Urinary Cortisol Measurements in Asthmatic Children Phase 3
Recruiting NCT04089085 - STRONGer Together: A Small Group Intervention for Children With Asthma and Anxiety/Depression N/A
Completed NCT03304067 - Asthma Control Study N/A
Completed NCT02451709 - STudy of Asthma Adherence Reminders N/A
Withdrawn NCT01451944 - Effect of Home Health Case Management on Asthma Morbidity N/A
Completed NCT00204828 - T Regulatory and Childhood Asthma
Completed NCT01472471 - Urinary 8-isoprostane is Elevated in Acute Childhood Asthma N/A
Completed NCT03278561 - General Risk Factors and Inflammatory Determinants in Older Patients With Asthma
Active, not recruiting NCT02702687 - Childhood Asthma Perception Study N/A
Active, not recruiting NCT03514485 - West Philadelphia Controls Asthma N/A
Not yet recruiting NCT02678949 - Changes in the Lung Clearance Index in Pediatric Patients With Asthma N/A
Completed NCT02404103 - Flunisolide HFA in Children With Small Airway Disease N/A
Completed NCT02341573 - Experienced Chinese Herbal Formulas on Pediatric Asthma N/A
Completed NCT03481673 - COPE for Children With Asthma: Intervention for Children With Asthma N/A
Recruiting NCT04250779 - Evaluating Efficacy of Smart Device in Assisting With Inhaler Technique and Adherence Early Phase 1
Completed NCT03696602 - More Relaxation by Deep Breath on Methacholine
Completed NCT02405962 - Training Parents by Acceptance and Commitment Therapy for Managing Childhood Asthma Care N/A
Not yet recruiting NCT04525586 - lncRNA-based Nomogram to Assist Childhood Asthma Diagnosis